以模型为依据的药物开发如何加速您的项目？
What is model-informed drug development (MIDD), and why is it so critical to informing the…
Certara2023 年 7 月 28 日
RAPS Sponsored Webcast: How to Plan for a Successful EMA Policy 0070 Submission
In September 2023, the European Medicines Agency (EMA) will reinstate their Policy 0070 requirement to…
Certara2023 年 7 月 20 日
AAPS eChalk talk: FDA Modernization Act – What Does it Mean for Pharmaceutical Scientists?
历史上，FDA 要求药物发现与开发项目必须包含动物试验。With the…
Certara2023 年 7 月 12 日
How QSP brings insights and accelerates bispecific antibody drug development
Wednesday, August 9th 2023 More than 50 bispecific antibodies are in oncology clinical development with…
Certara2023 年 6 月 29 日
Quantitative Systems Pharmacology (QSP) Model Applications in Inflammatory Bowel Disease (IBD) and Alzheimer’s Disease
Meet the Quantitative Systems Pharmacology (QSP) experts and view applications in Inflammatory Bowel Disease (IBD)…
Certara2023 年 6 月 29 日
Applying Technology to Expedite Regulatory Writing
Many medical writing capabilities and approaches have matured over the past several years opening the…
Certara2023 年 6 月 25 日
GlobalSubmit Review and You: How to Expedite the Submission Review Process
Have you ever wondered how you could speed up the submission review process without compromising…
Certara2023 年 6 月 25 日
What’s New for SEND 2023
This webinar will focus on several changes to the CDISC SEND standard that became active…
Certara2023 年 6 月 12 日
Unlocking Efficiency and Quality: What is New in Phoenix™ 8.4?
Join us for an exclusive webinar as Certara introduces the highly anticipated version 8.4 of…
Certara2023 年 6 月 5 日
